Utilization and Tolerability of Alternative Infliximab and Biosimilar Dosing Strategies Among Adult Patients in the Home Infusion Setting: A Retrospective Study

Natalie Garcia PharmD, Option Care Health
Andrew Chinn PharmD, BCSCP, Option Care Health
Cara Bivona, PharmD Option Care Health
Maria Giannakos PharmD, MBA, BCPS, BCSCP, FNHIA, Option Care Health
Christopher Roy PharmD, BCSCP, Option Care Health
Michelle Sahlani PharmD, Option Care Health
David Shepherd PharmD, CNSC, BCSCP, Option Care Health

The post Utilization and Tolerability of Alternative Infliximab and Biosimilar Dosing Strategies Among Adult Patients in the Home Infusion Setting: A Retrospective Study appeared first on National Home Infusion Association.